Evidence map›Paper›PMID 34446704›Full record

ArticleNature communications2021

Oral immune dysfunction is associated with the expansion of FOXP3

N Bhaskaran, E Schneider, F Faddoul, A Paes da Silva, R Asaad, A Talla, N Greenspan, A D Levine, D McDonald, J Karn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Enrichment ofFrontiers in immunology · 2026
    Article
  2. Article
  3. Review
  4. Dysbiosis modulates CD8iScience · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. [Immunological Causes of Oral Manifestations of HIV Infection: A Literature Review].Revista cientifica odontologica (Universidad Cientifica del Sur)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

N BhaskaranDepartment of Biological Sciences, School of Dental Medicine, Case Western Reserve University, Cleveland, OH, USA.
E SchneiderDepartment of Biological Sciences, School of Dental Medicine, Case Western Reserve University, Cleveland, OH, USA.
F FaddoulAdvanced Education in General Dentistry, School of Dental Medicine, Case Western Reserve University, Cleveland, OH, USA.
A Paes da SilvaDepartment of Periodontics, School of Dental Medicine, Case Western Reserve University, Cleveland, OH, USA.
R AsaadUniversity Hospitals Cleveland Medical Center AIDS Clinical Trials Unit, Division of Infectious Diseases & HIV Medicine, Cleveland, OH, USA.
A TallaDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
N GreenspanDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
A D LevineDepartment of Microbiology and Molecular Biology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.ORCID 0000-0002-5706-0667
D McDonaldDivision of AIDS, NIAID, NIH, Bethesda, MD, USA.
J KarnDepartment of Microbiology and Molecular Biology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.ORCID 0000-0002-2900-094X
M M LedermanUniversity Hospitals Cleveland Medical Center AIDS Clinical Trials Unit, Division of Infectious Diseases & HIV Medicine, Cleveland, OH, USA.
P PandiyanDepartment of Biological Sciences, School of Dental Medicine, Case Western Reserve University, Cleveland, OH, USA. pxp226@case.edu.ORCID 0000-0003-3688-0794
Case Western Reserve University · USOffice of AIDS Research · US

Funding

METABOLOME ANALYSES OF SALIVA SAMPLES FROM HIV+ PATIENTS ON cARTR01DE026923 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI Pushpa Pandiyan · 2017 to 2026
$4.5M
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune functionR01DA043253 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2016 to 2021
$4.3M
Repairing the intestinal epithelium from the dual action of HIV and drug useDP1DA037997 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2015 to 2019
$4.1M
NIDA NIH HHS DP1 DA037997NIDA NIH HHS R01 DA043253NIDCR NIH HHS R01 DE026923
6 · The paper itself

Abstract

Residual systemic inflammation and mucosal immune dysfunction persist in people living with HIV, despite treatment with combined anti-retroviral therapy, but the underlying immune mechanisms are poorly understood. Here we report that the altered immune landscape of the oral mucosa of HIV-positive patients on therapy involves increased TLR and inflammasome signaling, localized CD4

Indexed as

AmphiregulinCD4-Positive T-LymphocytesForkhead Transcription FactorsHIV-1HIV InfectionsHumansInterleukin-1betaLymphocyte ActivationMouth MucosaProgrammed Cell Death 1 ReceptorT-LymphocytesAmphiregulinForkhead Transcription FactorsFOXP3 protein, humanInterleukin-1betaProgrammed Cell Death 1 Receptor

Identifiers

PMID34446704
PMCPMC8390677
OpenAlexW3194526457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.